Status | Study |
Completed |
Study Name: Observational Study of Acute Intermittent Porphyria Patients Condition: Acute Intermittent Porphyria Date: 2014-02-27 |
Recruiting |
Study Name: Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact Condition: Erythropoietic Protoporphyria EPP X-Linked Protoporphyria Date: 2012-09-14 |
Recruiting |
Study Name: Phase III Confirmatory Study in Erythropoietic Protoporphyria Condition: Erythropoietic Protoporphyria Date: 2012-05-22 Interventions: Drug: Afamelanotide One 16mg s |
Recruiting |
Study Name: Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda Condition: Porphyria Cutanea Tarda Date: 2012-04-05 Interventions: Drug: Hydroxychloroquine 100 m |
Terminated |
Study Name: Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria Condition: Erythropoietic Protoporphyria (EPP) X Linked Erythropoietic Protoporphyria Date: 2012-03-05 Interventions: Drug: Isoniazid Isoniazid 5 mg/Kg up to 300 mg per day. Oral tablets. 2 months. |
Recruiting |
Study Name: Clinical Diagnosis of Acute Porphyria Condition: Hereditary Coproporphyria (HCP) Acute Intermittent Porphyria (AIP) Date: 2012-02-16 |
Recruiting |
Study Name: Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda Condition: Porphyria Cutanea Tarda Date: 2011-01-26 Interventions: Drug: Exjade Orodispersible Tablet, 10 mg/Kg/day ± 5 mg/Kg/day during 24 weeks Deferasirox should b |
Completed |
Study Name: Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP) Condition: Erythropoietic Protoporphyria Date: 2010-03-30 Interventions: Drug: Afamelanotide One 16mg s |
Completed |
Study Name: Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP) Condition: Erythropoietic Protoporphyria Date: 2009-09-17 Interventions: Drug: Afamelanotide One 16mg s |
Completed |
Study Name: Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda Condition: Porphyria Cutanea Tarda Date: 2008-01-10 Interventions: Drug: Deferasirox 250 mg of deferasirox once daily for 6 months |